RegulatoryAlerts Logo
RegulatoryAlerts
InsightsBlogPricingSign InStart Free Trial
All CDSCO (India) updates
CDSCO (India)
NOTICE
SoP - Compounding of Offences Rules, 2025
Published: 1/1/2026Detected: 9/11/2026

Summary preview

Introduces a policy mechanism for handling regulatory “offences” through compounding under India’s CDSCO framework, potentially enabling certain non-compliance matters to be settled without full enforcement escalation.

Get the full analysis, free

Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.

Create free account
manufacturing
quality
safety
labeling
#CDSCO
#compounding
#regulatory offences
#settlement
#compliance

Official Source Document
Source Verified

Access the original document directly from INDIA CDSCO.

View Official Document

More from CDSCO (India)

  • 28.10.2026 G.S.R. 954(E)_Draft​ Amendment of Rule 43A of the Drugs Rules, 1945 to include various ICDs/Port/SEZs for the import of Drugs/ Medical Devices/ Cosmetics in India10/28/2026
  • 28.10.2026 G.S.R. 955(E)_Draft Notification for amendment in the Drugs Rules, 1945 for requirement of an authorised person responsible for batch release of product10/28/2026
  • 2026.10.28 G.S.R. 951(E)_Notification regarding rationalization of shelf life under Rule 31 of Drugs Rules, 194510/28/2026
  • Appointment of Central Compounding Authority Order10/28/2026
  • Misleading or false claims of the product FatX solution registered under COS-2 vide RC no. RC/COS-003300 by the firm M/s Tekno Midas Aesthetics10/28/2026

Get CDSCO (India) alerts in your inbox as they are published.

Free plan, 2-minute setup, no credit card required.

RegulatoryAlerts Logo
RegulatoryAlerts

Automated regulatory intelligence monitoring for pharmaceutical and biotech professionals. Track FDA, EMA, and Health Canada updates seamlessly.

Product

  • Insights
  • Updates by Therapeutic Area
  • FDA Updates
  • EMA Updates
  • Pricing
  • Features
  • Request Demo

Resources

  • Integration Guides
  • Regulatory Glossary
  • EMA Timeline
  • Best Practices
  • Therapeutic Areas

Company

  • About Us
  • Blog
  • Contact
  • Security
  • Privacy Policy
  • Terms of Service
  • © 2026 RegulatoryAlerts. All rights reserved.

    Not affiliated with the FDA, EMA, or Health Canada.